Trusted cannabis guides & exclusive deals Medical Disclaimer: Content for informational purposes only.
THC & Cannabinoids ⏱ πŸ“… Nov 15, 2026

Exploring Cannabichromene (CBC): Unique Therapeutic Benefits

A small amber glass bottle of golden oil on a light marble surface with fresh green hemp leaves and a magnifying glass in soft natural daylight
Table of Contents

    Cannabichromene (CBC) is a non-psychoactive cannabinoid β€” it does not get you high because it binds CB1 weakly. It forms from CBGA (cannabigerolic acid) via CBCA, the same precursor that produces THC and CBD. CBC is the least-studied of the major minor cannabinoids: no human trials exist. Its reputation rests on cell and animal studies suggesting anti-inflammatory and analgesic activity, plus one mouse-cell study on neural stem cells that is routinely overstated. This guide separates what is known from what is hoped.

    CBC vs THC vs CBD

    CBC THC CBD
    Psychoactive? No Yes No
    CB1 binding Weak Strong Low affinity (acts via other targets)
    Main studied actions TRP channels, anandamide uptake (in vitro) CB1/CB2 agonist Multiple targets (5-HT1A, TRPV1, etc.)
    Human trials None Extensive Extensive

    How CBC is thought to work

    CBC does not act primarily through CB1/CB2. In laboratory studies it activates TRP channels (TRPA1, TRPV1 β€” the same family capsaicin acts on, relevant to pain perception) and inhibits anandamide uptake in vitro (De Petrocellis et al., 2011), which could prolong anandamide’s effects. Both findings are preclinical. The “bliss molecule” framing is marketing: anandamide is named from the Sanskrit ananda, and no human study shows CBC raises mood via anandamide. See our endocannabinoid system overview.

    The evidence, honestly graded

    • Pain/inflammation: rodent studies only (e.g., CBC reduced inflammation in mouse models). No human data.
    • Neurogenesis: one 2013 study (Shinjyo & Di Marzo) found CBC promoted viability of mouse neural stem progenitor cells in vitro. This is not evidence CBC grows brain cells in people.
    • Acne: one in vitro study (OlΓ‘h et al., 2016) found CBC reduced sebum production in human sebocytes. No clinical trial.
    • Anti-viral: no evidence. Claims to this effect should be disregarded.

    The NCCIH cannabis overview covers the evidence standards that CBC claims fail to meet. See our CBG guide and our CBD vs THC guide.

    Safety and legality

    No human safety data, no established dose, no interaction data. CBC products are unregulated; the FDA’s warnings on unregulated cannabinoid products apply. Legality: hemp-derived CBC follows the P.L. 119-37 framework (late 2026) β€” verify current law. See our Delta-8 guide.

    Frequently asked questions

    What is cannabichromene (CBC)?

    A non-psychoactive cannabinoid formed from CBGA via CBCA. Binds CB1 weakly; acts mainly via TRP channels in laboratory studies.

    How does CBC affect the body?

    Unknown in humans. Preclinical studies suggest anti-inflammatory and analgesic activity via TRP channels and anandamide uptake inhibition.

    Can CBC get you high?

    No. CBC is non-psychoactive and binds CB1 weakly.

    What benefits does CBC offer?

    None established in humans. Pain, inflammation, and brain-health claims rest on cell and animal studies only.

    How is CBC different from CBD?

    Different molecule, different mechanism (CBC: TRP channels; CBD: multiple targets), and far less evidence β€” CBD has human trials, CBC has none.

    Browse the THC & Cannabinoids hub.

    πŸ””

    Affiliate Disclosure

    The CakeHeights Editorial Team is committed to providing accurate, research-backed information about cannabis and hemp products. Some links on this page are affiliate links, meaning we may earn a commission at no extra cost to you if you make a purchase through them. Our recommendations are based on independent research, testing, and analysis. We only promote products we believe offer genuine value to our readers. Learn more β†’

    CakeHeights com
    CakeHeights Editorial Team
    Share: f 𝕏 P βœ‰
    Scroll to Top